Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing blood loss after cesarean section
IRCT20140420017365N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid with Placebo (distilled water) (2 arms). Primary endpoint: Blood loss after cesarean section. Started Sep 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20140420017365N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140420017365N4.